ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,132Medicare Part D Prescriptions Filled, Including Refills

Rank: 134 out of 1006

$592K Total Retail Price of All Prescriptions

Rank: 161 out of 1006

318 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 318 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 318 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 6,214 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 357 220 1 2
WARFARIN SODIUM 339 339 2 8
FUROSEMIDE 333 323 3 6
LISINOPRIL 315 225 4 3
SIMVASTATIN 226 166 5 1
RISPERIDONE 217 52 6 40
POLYETHYLENE GLYCOL 3350 205 44 7 91
OMEPRAZOLE 196 138 8 9
AMLODIPINE BESYLATE 191 173 9 4
GABAPENTIN 189 117 10 20
METOPROLOL TARTRATE 188 184 11 7
TRAZODONE HCL 179 156 12 21
POTASSIUM CHLORIDE 172 155 13 30
DIVALPROEX SODIUM 155 24 14 53
RANITIDINE HCL 141 98 15 63
ATORVASTATIN CALCIUM 114 70 16 5
METOPROLOL SUCCINATE 113 100 17 12
SERTRALINE HCL 112 87 18 19
GENERLAC 109 0 19 140
LANTUS 102 77 20 43
ENULOSE 94 0 21 201
BENZTROPINE MESYLATE 93 22 R 22 106
DONEPEZIL HCL 93 93 22 17
QUETIAPINE FUMARATE 92 73 24 45
MIRTAZAPINE 90 90 25 26
LEVETIRACETAM 90 14 25 72
CARBAMAZEPINE 89 0 27 124
NEXIUM 86 61 28 28
METFORMIN HCL 82 69 29 10
HYDROCHLOROTHIAZIDE 75 59 30 11
ATENOLOL 74 53 31 13
ALENDRONATE SODIUM 73 27 32 29
LOVASTATIN 69 69 33 44
ALLOPURINOL 67 63 34 31
PREDNISONE 63 63 35 33
TAMSULOSIN HCL 62 23 36 23
HYDROCODONE-ACETAMINOPHEN 61 45 S3 37 25
CITALOPRAM HBR 59 58 38 24
DIOVAN 58 56 39 16
NAMENDA 54 54 40 34
SEROQUEL 54 43 40 97
LACTULOSE 52 26 42 104
NITROFURANTOIN MONO-MACRO 51 37 43 180
PRAVASTATIN SODIUM 50 43 44 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 4, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.